A motor function measure scale for neuromuscular diseases. Construction and validation study.
Bérard C, Payan C, Hodgkinson I, Fermanian J and the MFM collaborative study group.
Neuromuscular Disorders. 2005. 15 : 463-470.
Validation study of a new scale for motor function measurement developed for neuromuscular diseases, the MFM. The validation study included 303 patients, aged 6–62 years. The scale comprised 32 items, in three motor function domains: standing position and transfers, axial and proximal motor function, distal motor function. The scale is reliable, does not require any special equipment and is well-accepted by patients.
Keywords: neuromuscular diseases, motor function, metrology, scale, validation study, clinical trials
Articles in scientific journals
Evaluation of muscle oxygenation by near-infrared spectroscopy in patients with Becker muscular dystrophy
Allart E, Olivier N, Hovart H, Thevenon A, Tiffreau V. Neuromuscul Disord. 2012. 22(8): 720-7. The primary objective of the study was to describe and compare muscle oxygenation patterns during constant-load exercise in patients with Becker Muscular Dystrophy (BMD) and...
Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: evidence from a safety study with pilot efficacy measures in adult dystrophic patients.
D'Angelo MG, Gandossini S, Martinelli Boneschi F, Sciorati C, Bonato S, Brighina E, Comi GP, Turconi AC, Magri F, Stefanoni G, Brunelli S, Bresolin N, Cattaneo D, Clementi E. Pharmacol Res. 2012. 65(4): 472-9. The main of this monocentric pilot study was to evaluate...
Gait Assessment in Children With Duchenne Muscular Dystrophy During Long-Distance Walking
Ganea R, Jeannet PY, Paraschiv-Ionescu A, Goemans N, Piot C, Van den Hauwe M, Aminian K. J Child Neurol. 2012. 27: 1 30-38. Gait patterns of 25 children with Duchenne muscular dystrophy were compared to that of healthy children. Authors showed that Duchenne muscular...
Motor function measure scale, steroid therapy and patients with Duchenne muscular dystrophy.
Silva EC, Machado DL, Resende MB, Silva RF, Zanoteli E, Reed UC. Arq Neuropsiquiatr. 2012. 70(3): 191-5. Description of the evolution of the motor function of 33 DMD patients (27 ambulant and 6 non ambulant at inclusion) treated with steroids during 18 month assessed...
Quantitative MRI can detect subclinical disease progression in muscular dystrophy.
Fischmann A, Hafner P, Fasler S, Gloor M, Bieri O, Studler U, Fischer D. J Neurol. 2012. 259(8): 1648-54. The aim of this study was to compare different methods of quantitative and semiquantitative MRI in order to validate clinical parameters for the follow-u of...
The assisted 6-minute cycling test to assess endurance in children with a neuromuscular disorder.
Jansen M, De Jong M, Coes HM, Eggermont F, Van Alfen N, De Groot IJ. Muscle Nerve. 2012. 46(4): 520-3. Development of the "assisted 6-minute cycling" aiming to assess DMD patients' endurance.MFM is use as a gold standard.PubMed linkKeywords: Assisted 6-minute cycling...